Structural evidence for substrate-induced synergism and half-sites reactivity in biotin carboxylase.

Protein Science : a Publication of the Protein Society
Igor MochalkinG L Waldrop

Abstract

Bacterial acetyl-CoA carboxylase is a multifunctional biotin-dependent enzyme that consists of three separate proteins: biotin carboxylase (BC), biotin carboxyl carrier protein (BCCP), and carboxyltransferase (CT). Acetyl-CoA carboxylase is a potentially attractive target for novel antibiotics because it catalyzes the first committed step in fatty acid biosynthesis. In the first half-reaction, BC catalyzes the ATP-dependent carboxylation of BCCP. In the second half-reaction, the carboxyl group is transferred from carboxybiotinylated BCCP to acetyl-CoA to produce malonyl-CoA. A series of structures of BC from several bacteria crystallized in the presence of various ATP analogs is described that addresses three major questions concerning the catalytic mechanism. The structure of BC bound to AMPPNP and the two catalytically essential magnesium ions resolves inconsistencies between the kinetics of active-site BC mutants and previously reported BC structures. Another structure of AMPPNP bound to BC shows the polyphosphate chain folded back on itself, and not in the correct (i.e., extended) conformation for catalysis. This provides the first structural evidence for the hypothesis of substrate-induced synergism, which posits that ATP ...Continue Reading

References

Jan 7, 1998·Protein Science : a Publication of the Protein Society·M Y Galperin, E V Koonin
May 23, 1998·Critical Reviews in Biochemistry and Molecular Biology·N BurkhardtK H Nierhaus
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
May 24, 2000·The Journal of Biological Chemistry·J B ThodenG L Waldrop
Apr 26, 2001·Acta Crystallographica. Section D, Biological Crystallography·T J Oldfield
Sep 7, 2001·Annual Review of Microbiology·J W Campbell, J E Cronan
Jul 18, 2002·Progress in Lipid Research·John E Cronan, Grover L Waldrop
Mar 3, 2004·Acta Crystallographica. Section D, Biological Crystallography·Shin KondoHiroki Kondo
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jun 14, 2005·Advanced Drug Delivery Reviews·Stuart B Levy
Dec 13, 2005·BMC Bioinformatics·K V Brinda, Saraswathi Vishveshwara
Apr 6, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jue ShiBruce A Palfey
May 2, 2006·The Journal of Biological Chemistry·Yong-Mei ZhangCharles O Rock
Feb 3, 2007·Journal of Theoretical Biology·Marcio S de Queiroz, Grover L Waldrop
Jul 24, 2007·Acta Crystallographica. Section D, Biological Crystallography·Shin KondoHiroki Kondo
Aug 8, 2007·Journal of Molecular Biology·Evgeny Krissinel, Kim Henrick
Feb 15, 2008·The Journal of Physical Chemistry. B·Sten O Nilsson LillGrover L Waldrop

❮ Previous
Next ❯

Citations

Aug 8, 2012·Cellular and Molecular Life Sciences : CMLS·Liang Tong
Dec 21, 2011·Applied Microbiology and Biotechnology·S W PolyakG W Booker
Oct 12, 2012·Journal of Inherited Metabolic Disease·Lorena Gallego-VillarLourdes R Desviat
Jan 27, 2012·The Journal of Biological Chemistry·Chen FanSong Xiang
Oct 27, 2012·Hybridoma·Teerakul ArpornsuwanJohn C Wallace
Apr 5, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Michal Brylinski, Grover L Waldrop
Feb 26, 2013·Analytical Biochemistry·Sherrisse K BryantS Douglass Gilman
Sep 13, 2012·Protein Science : a Publication of the Protein Society·Grover L WaldropMartin St Maurice
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·J Richard MillerC Kendall Stover
Feb 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Christopher T Walsh, Michael A Fischbach
Aug 4, 2015·Pharmacology Research & Perspectives·Zachary E Tibbs, Charles N Falany
Mar 12, 2015·Drug Metabolism and Pharmacokinetics·Zachary E TibbsCharles N Falany
Jun 25, 2016·Biochemical Pharmacology·Zachary E Tibbs, Charles N Falany
Aug 27, 2014·Archives of Biochemistry and Biophysics·Adam D LietzanMartin St Maurice
Mar 5, 2019·Electrophoresis·Thu H NguyenS Douglass Gilman
Feb 13, 2020·Future Medicinal Chemistry·Xin Wu, Tonghui Huang
Jan 31, 2020·Frontiers in Chemistry·Elvis Awuni
Jun 23, 2009·ACS Chemical Biology·Grover L Waldrop
Jul 10, 2009·The Journal of Physical Chemistry. B·Brian R NovakMarcio S de Queiroz
May 1, 2021·RSC Chemical Biology·Adeline EspinasseErin E Carlson
Jun 17, 2021·Microbiology and Molecular Biology Reviews : MMBR·John E Cronan
Jan 18, 2011·Journal of Medicinal Chemistry·Veronika ŠkedeljAnamarija Zega

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.